Wolverine Asset Management’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Wolverine Asset Management’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,722	Closed	-$583K	–	2651
2021 Q1	$583K	Buy	+9,722	New	+$352K	﹤0.01%	856

Wolverine Asset Management's PAND Position: Q2 2021 in Review

Wolverine Asset Management sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 9,722 shares — an estimated $583K sold.

Wolverine Asset Management first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $583K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Wolverine Asset Management reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Wolverine Asset Management sold 9,722 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $583K.
Wolverine Asset Management first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Wolverine Asset Management's Pandion Therapeutics Inc. Common Stock position peaked at $583K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.